Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis-Reference-Cited by-同舟云学术

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis

Published:2016-11-03 Issue:12 Volume:87 Page:1343-1349
ISSN:0022-3050
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
language:en
Short-container-title:J Neurol Neurosurg Psychiatry

Author:

Tao Chunrong,Simpson Steve^ORCID,van der Mei Ingrid,Blizzard Leigh,Havrdova Eva,Horakova Dana,Shaygannejad Vahid,Lugaresi Alessandra,Izquierdo Guillermo,Trojano Maria,Duquette Pierre,Girard Marc,Grand'Maison Franois,Grammond Pierre,Alroughani Raed^ORCID,Terzi Murat,Oreja-Guevara Celia,Sajedi Seyed Aidin,Iuliano Gerardo,Sola Patrizia,Lechner-Scott Jeannette,Pesch Vincent Van,Pucci Eugenio,Bergamaschi Roberto,Barnett Michael,Ramo Cristina,Singhal Bhim,LA Spitaleri Daniele,Slee Mark,Verheul Freek,Fernández Bolaños Ricardo,Amato Maria Pia,Cristiano Edgardo,Granella Franco,Hodgkinson Suzanne,Fiol Marcela,Gray Orla,McCombe Pamela,Saladino Maria Laura,Sánchez Menoyo José Luis,Shuey Neil,Vucic Steve,Shaw Cameron,Deri Norma,Arruda Walter Oleschko,Butzkueven Helmut,Spelman Tim,Taylor Bruce V

Publisher

BMJ

Subject

Psychiatry and Mental health,Clinical Neurology,Surgery

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies;Journal of Neurology;2023-09-28

2. Environmental Influences on Risk and Disease Course in Pediatric Multiple Sclerosis;Seminars in Pediatric Neurology;2023-07

3. The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update;Nutrients;2023-06-30

4. Triggering multiple sclerosis at conception and early gestation: The variation in ultraviolet radiation is as important as its intensity;Heliyon;2023-06

5. Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis;Pharmacology & Therapeutics;2023-06